首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives
【24h】

Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives

机译:植物磷脂络合技术改善植物活性物质药代动力学的研究进展与展望

获取原文
获取原文并翻译 | 示例
           

摘要

The phyto-phospholipid complexation technique has emerged as one of the leading methods of improving bioavailability of phytopharmaceuticals having poor competency of solubilizing and crossing the biological membranes. Several plant actives in spite having potent in vitro pharmacological activities have failed to demonstrate similar in vivo response. Such plant actives have been made more effective systemically by incorporating them with dietary phospholipids forming new cellular structures which are amphipathic in nature. In the last few years phospholipids have been extensively explored for improved bioavailability and efficacy of plant drugs. Further, it is also much relevant to mention that phospholipids show unique compatibility with biological membranes and have inherent hepatoprotective activity. Different methods have been adopted to formulate phospholipid complexes of plant extractives utilizing varying solvent systems, molar ratios of drug/phospholipids and different drying techniques. Some methods of formulating such drug-phospholipid complexes have been patented as well. However, the stability of phyto-phospholipid complexes is still a matter of concern which needs attention. But still a number of products exploiting this technique are under clinical trials and some of them are now in market. The current review highlights key findings of recent years with our own viewpoints which can give the new directions to this strategy and also includes advancements in the technical aspects of phyto-phospholipid formulations which have been done in the recent past with future challenges.
机译:植物磷脂络合技术已经成为提高溶解和穿过生物膜能力差的植物药物生物利用度的主要方法之一。尽管具有有效的体外药理活性的几种植物活性物未能证明相似的体内反应。通过将它们与膳食磷脂掺入形成天然的两亲性的新细胞结构,已使这些植物活性剂在系统上更有效。在最近几年中,已经广泛地探索磷脂以改善植物药物的生物利用度和功效。此外,提及磷脂与生物膜具有独特的相容性并具有固有的肝保护活性,这也非常相关。已经采用了不同的方法来利用不同的溶剂系统,药物/磷脂的摩尔比和不同的干燥技术来配制植物提取物的磷脂复合物。配制这种药物-磷脂复合物的某些方法也已获得专利。但是,植物磷脂复合物的稳定性仍然是一个值得关注的问题。但是仍然有许多利用这种技术的产品正在临床试验中,其中一些现在已经投放市场。当前的综述以我们自己的观点突出了近年来的主要发现,这些观点可以为该策略提供新的方向,还包括植物磷脂制剂的技术方面的进步,这些方面在最近已经完成并面临着未来的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号